1,3-dicarboxamide-oxindoles as antiinflammatory agents
申请人:Pfizer Inc.
公开号:US04725616A1
公开(公告)日:1988-02-16
1,3-Dicarboxamidooxindoles as antiinflammatory agents prepared by reaction of the 1-carbamoyloxindole with an isocyanate or by aminolysis of the corresponding alkyl 1-carbamoyloxindole-3-carboxylate.